In summary, our cross-sectional molecular analyses support the notion of eosinophilic bronchiectasis as predominantly IL-5 driven; however, our statistical power is weak and our findings should be interpreted accordingly. The gene discussed is IL5; the disease is eosinophilic bronchiectasis.